EntryPoint Capital’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$490K	Buy	60,573 +10,043	+20%	+$81.2K	0.25%	105
2025 Q1	$423K	Buy	+50,530	New	+$423K	0.19%	164
2024 Q4	–	Sell	-12,725	Closed	-$106K	–	706
2024 Q3	$106K	Buy	+12,725	New	+$106K	0.06%	552